Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Comparison of the immune response during acute and chronic Staphylococcus aureus infection.

Brady RA, Mocca CP, Plaut RD, Takeda K, Burns DL.

PLoS One. 2018 Mar 29;13(3):e0195342. doi: 10.1371/journal.pone.0195342. eCollection 2018.

2.
3.

Immunogenicity analysis of Staphylococcus aureus clumping factor A genetic variants.

Brady RA, Mocca CP, Burns DL.

Clin Vaccine Immunol. 2013 Aug;20(8):1338-40. doi: 10.1128/CVI.00275-13. Epub 2013 Jun 26.

4.

Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.

Brady RA, Mocca CP, Prabhakara R, Plaut RD, Shirtliff ME, Merkel TJ, Burns DL.

PLoS One. 2013 Apr 29;8(4):e63040. doi: 10.1371/journal.pone.0063040. Print 2013.

5.

Stably luminescent Staphylococcus aureus clinical strains for use in bioluminescent imaging.

Plaut RD, Mocca CP, Prabhakara R, Merkel TJ, Stibitz S.

PLoS One. 2013;8(3):e59232. doi: 10.1371/journal.pone.0059232. Epub 2013 Mar 12.

6.

A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates.

Kubler-Kielb J, Majadly F, Biesova Z, Mocca CP, Guo C, Nussenzweig R, Nussenzweig V, Mishra S, Wu Y, Miller LH, Keith JM, Liu TY, Robbins JB, Schneerson R.

Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1172-7. doi: 10.1073/pnas.0913374107. Epub 2009 Dec 28.

Supplemental Content

Loading ...
Support Center